What is the difference between Air 90% Carbon Dioxide 10% and Gadobutrol?

Air 90% Carbon Dioxide 10% and Gadobutrol are both Diagnostic Agents, so they work through the same broad mechanism. They differ in dosing, half-life, side-effect frequency, and how individual patients tolerate them. See the head-to-head sections below for the specifics.

Can Air 90% Carbon Dioxide 10% and Gadobutrol be used for the same conditions?

Both medications are prescribed for overlapping indications including See full prescribing information. Always verify with your prescriber and the current FDA label before switching.

Is Air 90% Carbon Dioxide 10% the same as Gadobutrol?

No. Air 90% Carbon Dioxide 10% (Air 90% Carbon Dioxide 10%) and Gadobutrol (Gadobutrol) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Which has fewer side effects, Air 90% Carbon Dioxide 10% or Gadobutrol?

Side-effect frequency varies by individual. The side-effect comparison section on this page shows FAERS-reported events for each drug side by side. FAERS is voluntary reporting, so it reflects what patients and clinicians chose to report, not absolute population risk.

Can I switch from Air 90% Carbon Dioxide 10% to Gadobutrol?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

Air 90% Carbon Dioxide 10% vs Gadobutrol

Compare Air 90% Carbon Dioxide 10% (Air 90% Carbon Dioxide 10%) and Gadobutrol (Gadobutrol), clinical data, side effects, and patient experiences.

Air 90% Carbon Dioxide 10%

Air 90% Carbon Dioxide 10% · Diagnostic Agent

How it works

Diagnostic Agent agent

Approved for

See full prescribing information

Respiratory (inhalation)Tablet

Gadobutrol

Gadobutrol · Diagnostic Agent

How it works

12.1 Mechanism of Action In MRI, visualization of normal and pathological tissue depends in part on variations in the radiofrequency signal intensity that occurs with: • Difference...

Approved for

including term neonates ( 1.3 ) • To assess myocardial perfusion (stress

including term neonates

to evaluate known or suspected supra-aortic or renal artery disease. 1.4 Cardiac MRI Gadobutrol injection is indicated for use in cardiac MRI (CMRI) to assess myocardial perfusion (stress

rest) and late gadolinium enhancement in adult patients with known or suspected coronary artery disease (CAD).

IntravenousTablet

Quick Comparison

Air 90% Carbon Dioxide 10%Gadobutrol

Drug Class

Diagnostic Agent

Route

Respiratory (inhalation)

Intravenous

Half-Life

N/A

FDA Approved

N/A

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

Air 90% Carbon Dioxide 10%

No data

Gadobutrol

Nausea

>10%

Vomiting

>10%

Itching

>10%

Shortness of Breath

1-10%

Dizziness

0.1-1%

Rash

0.1-1%

Cough

0.1-1%

Headache

0.1-1%

FDA Warnings

Air 90% Carbon Dioxide 10%

No specific warnings

Gadobutrol

5 WARNINGS AND PRECAUTIONS • Hypersensitivity Reactions: Anaphylactic and other hypersensitivity reactions with cardiovascular, respiratory or cutaneous manifestations, ranging from mild to severe, including death, have occurred
1 Risk Associated with Intrathecal Use Intrathecal administration of GBCAs can cause serious adverse reactions including death, coma, encephalopathy, and seizures
2 Nephrogenic Systemic Fibrosis GBCAs increase the risk for nephrogenic systemic fibrosis (NSF) among patients with impaired elimination of the drugs
The GBCA-associated NSF risk appears highest for patients with chronic, severe kidney disease (GFR 60 years, diabetes mellitus or chronic hypertension), estimate the GFR through laboratory testing

Clinical Trial Data

No head-to-head clinical studies found for Air 90% Carbon Dioxide 10% vs Gadobutrol.

Air 90% Carbon Dioxide 10% vs Gadobutrol: What You Should Know

Key Differences

Both Air 90% Carbon Dioxide 10% and Gadobutrol belong to the Diagnostic Agent class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. Air 90% Carbon Dioxide 10% is administered via Respiratory (inhalation), whereas Gadobutrol uses Intravenous. Route of administration can affect onset of action and patient adherence.

Safety Considerations

Gadobutrol carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

Gadobutrol vs Iopamidol→Carbon Dioxide vs Gadobutrol→Gadobutrol vs Iodixanol→Gadobutrol vs Iohexol→Gadobutrol vs Gadodiamide→Carbon Dioxide-Oxygen-Nitrogen Mixture vs Gadobutrol→

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

Air 90% Carbon Dioxide 10%: DailyMed label · FAERS adverse events · ClinicalTrials.gov
Gadobutrol: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

Air 90% Carbon Dioxide 10% vs Gadobutrol

Compare Air 90% Carbon Dioxide 10% (Air 90% Carbon Dioxide 10%) and Gadobutrol (Gadobutrol), clinical data, side effects, and patient experiences.

Air 90% Carbon Dioxide 10%

Air 90% Carbon Dioxide 10% · Diagnostic Agent

How it works

Diagnostic Agent agent

Approved for

See full prescribing information

Respiratory (inhalation)Tablet

Gadobutrol

Gadobutrol · Diagnostic Agent

How it works

12.1 Mechanism of Action In MRI, visualization of normal and pathological tissue depends in part on variations in the radiofrequency signal intensity that occurs with: • Difference...

Approved for

including term neonates ( 1.3 ) • To assess myocardial perfusion (stress

including term neonates

to evaluate known or suspected supra-aortic or renal artery disease. 1.4 Cardiac MRI Gadobutrol injection is indicated for use in cardiac MRI (CMRI) to assess myocardial perfusion (stress

rest) and late gadolinium enhancement in adult patients with known or suspected coronary artery disease (CAD).

IntravenousTablet

Quick Comparison

Air 90% Carbon Dioxide 10%Gadobutrol

Drug Class

Diagnostic Agent

Route

Respiratory (inhalation)

Intravenous

Half-Life

N/A

FDA Approved

N/A

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

Air 90% Carbon Dioxide 10%

No data

Gadobutrol

Nausea

>10%

Vomiting

>10%

Itching

>10%

Shortness of Breath

1-10%

Dizziness

0.1-1%

Rash

0.1-1%

Cough

0.1-1%

Headache

0.1-1%

FDA Warnings

Air 90% Carbon Dioxide 10%

No specific warnings

Gadobutrol

5 WARNINGS AND PRECAUTIONS • Hypersensitivity Reactions: Anaphylactic and other hypersensitivity reactions with cardiovascular, respiratory or cutaneous manifestations, ranging from mild to severe, including death, have occurred
1 Risk Associated with Intrathecal Use Intrathecal administration of GBCAs can cause serious adverse reactions including death, coma, encephalopathy, and seizures
2 Nephrogenic Systemic Fibrosis GBCAs increase the risk for nephrogenic systemic fibrosis (NSF) among patients with impaired elimination of the drugs
The GBCA-associated NSF risk appears highest for patients with chronic, severe kidney disease (GFR 60 years, diabetes mellitus or chronic hypertension), estimate the GFR through laboratory testing

Clinical Trial Data

No head-to-head clinical studies found for Air 90% Carbon Dioxide 10% vs Gadobutrol.

Air 90% Carbon Dioxide 10% vs Gadobutrol: What You Should Know

Key Differences

Safety Considerations

Gadobutrol carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.